View by Specialty

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

Hepatology News

SPONSORED CONTENT
Save
SPONSORED CONTENT
July 16, 2023
2 min watch
Save

New approach needed to manage adults with colorectal cancer, fatty liver

New approach needed to manage adults with colorectal cancer, fatty liver

Proteins and genetic material secreted by fatty liver cells stimulate the spread of colorectal cancer to the liver, study results published in Cell Metabolism showed.

SPONSORED CONTENT
July 15, 2023
4 min read
Save

EASL Congress 2023 rewind: What you may have missed; alcohol use, NASH data top agenda

EASL Congress 2023 rewind: What you may have missed; alcohol use, NASH data top agenda

EASL Congress 2023 has ended but, as the society’s official media partner, Healio was at the forefront covering the latest in liver disease. Wondering what you may have missed? Healio recaps the biggest news disrupting the specialty.

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

SPONSORED CONTENT
July 14, 2023
1 min read
Save

CDC recommends single-visit testing for hepatitis C

CDC recommends single-visit testing for hepatitis C

In new guidance, the CDC recommended that the two-step testing process for hepatitis C virus be completed in one visit, eliminating the need for multiple visits, which often leads to incomplete testing.

SPONSORED CONTENT
July 13, 2023
2 min read
Save

Use of simvastatin plus rifaximin not supported in patients with decompensated cirrhosis

Use of simvastatin plus rifaximin not supported in patients with decompensated cirrhosis

Simvastatin plus rifaximin did not reduce progression to acute-on-chronic liver failure, complications from cirrhosis or risk for death in patients with decompensated cirrhosis, according to data presented at EASL Congress.

SPONSORED CONTENT
July 13, 2023
3 min read
Save

Malpractice insurance is a physician’s first line of defense

Malpractice insurance is a physician’s first line of defense

Concerns about potential malpractice liability are top of mind for many physicians of all specialties. This is not surprising given recent verdicts in medical malpractice actions that have awarded millions of dollars in damages to plaintiffs.

SPONSORED CONTENT
July 13, 2023
1 min read
Save

Lowering HCC incidence threshold in guidelines cost-effective, may improve early detection

Lowering HCC incidence threshold in guidelines cost-effective, may improve early detection

Research demonstrated that hepatocellular carcinoma surveillance is cost-effective at a lower incidence threshold of 0.7% in virologically cured patients with hepatitis C virus, underscoring the need to update clinical guidelines.

SPONSORED CONTENT
July 12, 2023
2 min read
Save

Time-restricted eating may be ‘promising management option’ in patients with NAFLD, NASH

Time-restricted eating may be ‘promising management option’ in patients with NAFLD, NASH

Modifying the timing of daily energy intake may improve metabolic health and restore natural circadian rhythms among patients with nonalcoholic fatty liver disease, according to a review published in Gut.

SPONSORED CONTENT
July 11, 2023
2 min read
Save

Only 25% of patients with cirrhosis receive transplant referrals at safety-net hospitals

Only 25% of patients with cirrhosis receive transplant referrals at safety-net hospitals

Nearly 75% of patients with end-stage liver disease in safety-net hospitals were not referred for liver transplant evaluation, mostly due to active alcohol use or insurance issues, according to data published in JAMA Network Open.

SPONSORED CONTENT
July 11, 2023
3 min read
Save

BLOG: Corporate practice of medicine prohibitions

BLOG: Corporate practice of medicine prohibitions

Many states have corporate practice of medicine prohibitions.

SPONSORED CONTENT
July 11, 2023
2 min read
Save

1 in 10 patients with advanced liver disease develops liver-related event after HCV cure

1 in 10 patients with advanced liver disease develops liver-related event after HCV cure

The risk for hepatic decompensation and hepatocellular carcinoma remained constant after hepatitis C virus cure among patients with advanced chronic liver disease, underscoring the need for post-HCV risk stratification in the long term.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails